Edition:
India

BTG PLC (BTG.L)

BTG.L on London Stock Exchange

758.50GBp
14 Dec 2017
Change (% chg)

8.50 (+1.13%)
Prev Close
750.00
Open
747.50
Day's High
760.00
Day's Low
743.50
Volume
604,742
Avg. Vol
627,210
52-wk High
779.00
52-wk Low
528.36

Chart for

About

BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and... (more)

Overall

Beta: 0.11
Market Cap(Mil.): £2,754.76
Shares Outstanding(Mil.): 386.36
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-BTG says CFO Rolf Soderstrom to step down as executive director

* THAT AFTER 10 YEARS AS CHIEF FINANCIAL OFFICER (CFO) AT BTG, ROLF SODERSTROM IS TO STEP DOWN AS AN EXECUTIVE DIRECTOR OF COMPANY​

14 Nov 2017

BRIEF-BTG H1 ‍adjusted operating profit of 99.1 mln stg vs 78.8 mln stg

* H1 ‍ADJUSTED OPERATING PROFIT OF 99.1 MILLION STG VERSUS 78.8 MILLION STG YEAR AGO​

14 Nov 2017

BRIEF-BTG receives CPT codes for health insurance Varithena

* ‍new payment rates and automatic electronic processing of claims effective 1 january 2018​

06 Nov 2017

UK's BTG to buy Roxwood Medical for up to $80 million

British drugs company BTG Plc said on Thursday it will buy U.S.-based cardiovascular catheter maker Roxwood Medical for up to $80 million.

05 Oct 2017

UK's BTG to buy Roxwood Medical for up to $80 mln

Oct 5 British drugs company BTG Plc said on Thursday it will buy U.S.-based cardiovascular catheter maker Roxwood Medical for up to $80 million.

05 Oct 2017

BRIEF-BTG acquires Roxwood Medical

* ACQUIRED ROXWOOD MEDICAL, A PROVIDER OF ADVANCED CARDIOVASCULAR SPECIALTY CATHETERS

05 Oct 2017

BRIEF-BTG Plc reiterates full year product sales guidance

* ‍SPECIALTY PHARMACEUTICALS IS EXPECTED TO GROW BY LOW-TO-MID SINGLE DIGITS AT CER IN FY, WEIGHTED AS EXPECTED TO FIRST HALF.​

05 Oct 2017

BTG ordered to pay damages of $55.8 mln to Wellstat

LONDON, Sept 20 British drugs company BTG has been ordered to pay damages of $55.8 million plus interest and costs to Wellstat Therapeutics in a dispute over the distribution of Vistogard, an antidote to the overdose of two chemotherapy drugs.

20 Sep 2017

BRIEF-BTG ordered to pay damages of $55.8 mln to Wellstat Therapeutics

* ‍a memorandum opinion has been issued against btg in its previously announced litigation with wellstat therapeutics corporation​

20 Sep 2017

BRIEF-Integrated Capital Services says board approves appointment of Bhavesh Chadha as CFO

* Incorporating wholly owned subsidiary company BTG IP Services Pvt. Ltd

20 Jul 2017

Earnings vs. Estimates